Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07461935) titled 'ALPs Single ChambEr New Device' on March 2.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Cairdac SA

Condition: Bradycardia Brady-tachy Syndrome AV Block Atrial Fibrillation (AF)

Intervention: Device: Leadless ventricular pacemaker implantation

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: June 2026

Target Sample Size: 10

To know more, visit https://clinicaltrials.gov/study/NCT07461935

Published by HT Digital Content Services with permission from ...